Trial NCT04060407

View at ClinicalTrials.gov 
Org. Study IDs: 7110-004
Secondary IDs: CD24-004-CINDI R44CA250889

Last trial update was posted on 2021-06-01

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Melanoma

Other Conditions

Metastatic Melanoma

Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID